ArticleCureus2025
Recurrent Post-traumatic Morel-Lavallée Lesion of the Hip and Thigh Treated With Open Capsulectomy and Povidone-Iodine Sclerotherapy: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Morel-Lavallée lesions (MLLs) are closed internal degloving injuries that may lead to persistent post-traumatic fluid collections. We report the case of a 65-year-old male patient with a recurrent MLL over the left hip and thigh following a fall. Initial management with aspiration and corticosteroid injection was unsuccessful, and open capsulectomy also failed to prevent recurrence. Due to the unavailability of conventional sclerosing agents, ultrasound-guided sclerotherapy using 10% povidone-iodine was performed. After two sessions, there was a marked reduction in the size of the lesion without complications. This case suggests that povidone-iodine may serve as a viable alternative sclerosant for recurrent MLLs when standard agents are inaccessible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.